Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Middle East and Africa Influenza Market Unceasing Growth with a CAGR of 6.75%

 



(PharmaNewsWire.Com, May 01, 2017 ) Middle-East and Africa Influenza Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 6.75% to reach USD 0.25 billion by 2021, from USD 0.18 billion in 2016.

For full report refer to http://www.marketdataforecast.com/market-reports/middle-east-and-africa-influenza-market-1709/

Influenza or flu is a transmittable respiratory disease which affects throat, nose and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be pandemic, seasonal or zoonotic. Influenza can be lethal if goes unnoticed and is considered as a major reason of mortality, globally. Some of the symptoms of influenza are cough, fever, runny or stuffy nose, sore throat, headache, fatigue, and body ache. Children below 2 years of age and elderly above 65 years of age are at vulnerable of developing chronic flu. Within Middle-East & Africa, Egypt has been worst affected by Influenza A (H5N1) in 2015.

Free sample of the report is available at http://www.marketdataforecast.com/market-reports/middle-east-and-africa-influenza-market-1709/request-sample

Key factors which affect and thereby cause changes to the market dynamics are studied essentially and are presented in a well-known way in the report. Some of those factors are
• Increasing public awareness and improve healthcare expenditure
• Cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses.
• A large section of population in the region are not immunized against influenza virus
• Antigenic shift of influenza virus, shortage of cold storage facility, and remote areas with limited accessibility.

Enquire more about the report here http://www.marketdataforecast.com/market-reports/middle-east-and-africa-influenza-market-1709/inquire

For granular level understanding the Influenza Market is segmented based on Product Type, Type, Application and Disease Indications, each being provided with Market Size Estimations and Y-o-Y Forecasts.

Based on Product Type:
• Introduction
• Vaccines
• Drugs
• Y-o-Y Growth Analysis, By Product
• Market Attractiveness Analysis, By Product
• Market Share Analysis, By Product
Based on Type:
• Introduction
• Safety Biomarkers
• Efficacy Biomarkers
• Validation Biomarkers
• Y-o-Y Growth Analysis, By Type
• Market Attractiveness Analysis, By Type
• Market Share Analysis, By Type
Based on Application:
• Introduction
• Diagnostics Development
• Drug Discovery and Development
• Personalised Medicine
• Disease Risk Assessment
• Other Applications
• Y-o-Y Growth Analysis, By Application
• Market Attractiveness Analysis, By Application
• Market Share Analysis, By Application
Based on Disease Indications:
• Introduction
• Cancer
• CardiovascularDisorders
• Neurological Disorders
• Immunological Disorders
• Other Diseases
• Y-o-Y Growth Analysis, By Disease Indications
• Market Attractiveness Analysis, By Disease Indications
 Market Share Analysis, By Disease Indications

On the basis of geographical areas, Middle-East and Africa market for Influenza Market is segmented into Middle-East region and Africa region.
Some of the key players that operate in the Middle-East and Africa Influenza Market include AstraZeneca (United Kingdom), Sanofi-Pasteur (U.S.), Novartis (Switzerland), F. Hoffmann-La Roche (Switzerland), Pfizer Inc. (U.S.), GlaxoSmithKline (U.K.), Abbott Laboratories (U.S.), Merck & Co. (U.S.), CSL Limited (Australia) and Mitsubishi Tanabe Pharma Corporation (Japan).

Annually, nearly half-million people die of influenza and, with the threat of an epidemic in any given year, disease prevention organizations and government agencies are dedicated to gaining control of the situation.
Many companies have been requested aid with the problem and others are furthering their position with backing from government agencies," notes Fitzgerald. “The next five years should see funding and support for many product development, pandemic prevention and research and development programs and/or control by worldwide governments, health professionals and organizations.

Buy now http://www.marketdataforecast.com/market-reports/middle-east-and-africa-influenza-market-1709/

The Middle-East and Africa Influenza Market report offers wide-range of scope:
• Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of Product Type, Type, Application and Disease Indications along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market

For more reports related to the Pharmaceuticals Market:

Middle-East and Africa Bladder Cancer Therapeutics Market: http://www.marketdataforecast.com/market-reports/Middle-East-and-Africa-bladder-cancer-therapeutics-market-1154/

Middle-East and Africa Cancer Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-cancer-monoclonal-antibodies-market-190/

Middle-East and Africa Immunotherapy Drugs Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-immunotherapy-drugs-market-1161/

Middle-East and Africa Orphan Drugs Market: http://www.marketdataforecast.com/market-reports/latin-america-orphan-drugs-market-1680/

Middle-East and Africa Precision Medicine Market: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-precision-medicine-market-1480/

About Market Data Forecast:
Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs. For more info kindly visit, www.marketdataforecast.com

Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases


Market Data Forecast

Abhishek

+1-888- 702-9626

abhishek@marketdataforecast.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com ™ - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC